Citation Tools

Download PDFPDF

Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA

Download to a citation manager

Cite this article as:
Zeng X, Wan X, Peng L, et al
Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA